Search Results

Journal is the official publication of the International Union of Immunological Societies

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announced that it has priced a public offering with gross proceeds to the Company expected to be approximately $8.0 million, before deducting placement agent fees and other estimated expenses payable by the Company.

Gain Therapeutics, Inc. announced the pricing of an underwritten public offering of 7,116,547 shares of its common stock at a public offering price of $1.35 per share and pre-funded warrants to purchase 1,031,602 shares of common stock in lieu of shares of common stock to certain investors.

Gain Therapeutics, Inc. announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering.

Monte Rosa Therapeutics, Inc. today announced the pricing of an underwritten public offering of 10,638,476 shares of its common stock at a public offering price of $4.70 per share.

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced the pricing of its upsized underwritten public offering of 9,066,972 American depositary shares (ADSs), each representing three ordinary shares, at a public offering price of $52.50 per ADS.